This document discusses how human factors engineering and user experience design can accelerate medical product development. It recommends implementing these practices early in development to avoid costly changes later. Following standards like IEC 62366 involves user research, usability testing, and risk analysis to identify and address usability issues. This helps ensure medical devices are safe, effective and easy to use as intended.
User Interface Design for Medical Devices - The Relationship Between Usabilit...UXPA Boston
User Interface Design for Medical Devices - The Relationship Between Usability and Safety
Rich Newman's presentation from the UXPA Boston 2016 conference
Lean what 21 CFR Parts 210 and 211 are and how you an implement these regulations in your organization. For more information and tips on compliance go to http://compliance-insight.com/fda-gcp-and-gmp-training/21-cfr-210-211/
EMMA International Consulting Group CEO, Dr. Carmine Jabri, will be cohosting a webinar with Jan Flegeau, Director of Regulatory Affairs, to give an overview of what’s to come from the EU MDR.
User Interface Design for Medical Devices - The Relationship Between Usabilit...UXPA Boston
User Interface Design for Medical Devices - The Relationship Between Usability and Safety
Rich Newman's presentation from the UXPA Boston 2016 conference
Lean what 21 CFR Parts 210 and 211 are and how you an implement these regulations in your organization. For more information and tips on compliance go to http://compliance-insight.com/fda-gcp-and-gmp-training/21-cfr-210-211/
EMMA International Consulting Group CEO, Dr. Carmine Jabri, will be cohosting a webinar with Jan Flegeau, Director of Regulatory Affairs, to give an overview of what’s to come from the EU MDR.
8 Steps You Should Be Taking to Implement an EU-MDR Compliance ProgramGreenlight Guru
The new MDR will affect all Medical Device manufacturers.
The availability of the text for the new European Medical Device Regulation allows manufacturers to start the process of assessing the impact it will have on their activities, and what they will need to do to be compliant with the revised requirements.
The MDR will overhaul some of the basic principles under which manufacturers have been working under the current MDD.
Implementing the MDR requires a structured approach, since the transition to new MDR CE certificates can last several years.
Watch the presentation here: https://www.greenlight.guru/webinar/eu-mdr-compliance-program-implementation
Design controls are not an easy subject to address during and after the design of medical devices and manufacturing processes. Design controls should drive the device design process, not be an afterthought. This session focuses on treating design as a separate entity within the quality management system, user needs vs. design inputs, continuation of design controls after the transfer process, design review and more.
In the last year or so the FDA and the EMA have issued new guidance/ draft guidance on "Process Validation".These align process validation activities with a product lifecycle concept and the International Conference on Harmonisation (ICH) guidances for industry, Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The earlier guidelines were developed before the elaboration of the new ICH guidelines.With these new guidelines, additional opportunities are available to verify the control of the process by alternative means to the manufacture of traditional process validation batches. The main objective of process validation remains that a process design yields a product meeting its pre-defined quality criteria. ICH Q8, Q9 and Q10 provide a structured way to define product critical quality attributes, design space, the manufacturing process and the control strategy. ICH Q8 refers to an ‘enhanced’ approach to pharmaceutical development which includes an alternative to the traditional process validation.
Continuous process verification [see definition in ICH Q8(R2) glossary] can be utilised in process validation protocols for the initial commercial production and for manufacturing process changes for the continual improvement throughout the remainder of the product lifecycle.
There is now a new paradigm in process validation. This presentation has been prepared from material available from FDA , EMA and ICH for beginners to have an overview of the new paradigm.
Steps to Compliance with the European Medical Device RegulationsApril Bright
The trilogue negotiations for the European Medical Device Regulations are expected to conclude by June. Whether or not the long-awaited regulations receive another postponement, orthopaedic manufacturers cannot put off preparation or they risk their ability to sell products in Europe. Dr. Tariah will walk attendees through the greatest pain points for orthopaedic manufacturers when complying with the new regulations.
Accelerating MedTech Product Development with UX and Human Factors EngineeringICS
A growing number of medtech companies are embracing User Experience (UX) Design and Human Factors Engineering (HFE) — not just to meet FDA regulations, but also to create more intuitive, more usable, and holistically better products. These practices required to promote safety and efficacy also provide an opportunity for your company to quickly deliver products that are more innovative, which can be a key differentiator in the competitive medical device market.
This webinar will be delivered jointly with our partners, human factors experts at UserWise, and will answer the questions: what is Human Factors Engineering and why is it important? We’ll also cover:
Human Factors guidance and regulations
Human Factors Engineering process overview
Differences between regulatory usability and UX
How to use UX to feed regulatory development
8 Steps You Should Be Taking to Implement an EU-MDR Compliance ProgramGreenlight Guru
The new MDR will affect all Medical Device manufacturers.
The availability of the text for the new European Medical Device Regulation allows manufacturers to start the process of assessing the impact it will have on their activities, and what they will need to do to be compliant with the revised requirements.
The MDR will overhaul some of the basic principles under which manufacturers have been working under the current MDD.
Implementing the MDR requires a structured approach, since the transition to new MDR CE certificates can last several years.
Watch the presentation here: https://www.greenlight.guru/webinar/eu-mdr-compliance-program-implementation
Design controls are not an easy subject to address during and after the design of medical devices and manufacturing processes. Design controls should drive the device design process, not be an afterthought. This session focuses on treating design as a separate entity within the quality management system, user needs vs. design inputs, continuation of design controls after the transfer process, design review and more.
In the last year or so the FDA and the EMA have issued new guidance/ draft guidance on "Process Validation".These align process validation activities with a product lifecycle concept and the International Conference on Harmonisation (ICH) guidances for industry, Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The earlier guidelines were developed before the elaboration of the new ICH guidelines.With these new guidelines, additional opportunities are available to verify the control of the process by alternative means to the manufacture of traditional process validation batches. The main objective of process validation remains that a process design yields a product meeting its pre-defined quality criteria. ICH Q8, Q9 and Q10 provide a structured way to define product critical quality attributes, design space, the manufacturing process and the control strategy. ICH Q8 refers to an ‘enhanced’ approach to pharmaceutical development which includes an alternative to the traditional process validation.
Continuous process verification [see definition in ICH Q8(R2) glossary] can be utilised in process validation protocols for the initial commercial production and for manufacturing process changes for the continual improvement throughout the remainder of the product lifecycle.
There is now a new paradigm in process validation. This presentation has been prepared from material available from FDA , EMA and ICH for beginners to have an overview of the new paradigm.
Steps to Compliance with the European Medical Device RegulationsApril Bright
The trilogue negotiations for the European Medical Device Regulations are expected to conclude by June. Whether or not the long-awaited regulations receive another postponement, orthopaedic manufacturers cannot put off preparation or they risk their ability to sell products in Europe. Dr. Tariah will walk attendees through the greatest pain points for orthopaedic manufacturers when complying with the new regulations.
Accelerating MedTech Product Development with UX and Human Factors EngineeringICS
A growing number of medtech companies are embracing User Experience (UX) Design and Human Factors Engineering (HFE) — not just to meet FDA regulations, but also to create more intuitive, more usable, and holistically better products. These practices required to promote safety and efficacy also provide an opportunity for your company to quickly deliver products that are more innovative, which can be a key differentiator in the competitive medical device market.
This webinar will be delivered jointly with our partners, human factors experts at UserWise, and will answer the questions: what is Human Factors Engineering and why is it important? We’ll also cover:
Human Factors guidance and regulations
Human Factors Engineering process overview
Differences between regulatory usability and UX
How to use UX to feed regulatory development
Usability Validation Testing of Medical Devices and SoftwareUXPA Boston
The U.S. FDA and international regulatory bodies require usability testing of medical devices, products, software, and systems as part of their overall validation. Manufacturers must demonstrate that all potential use-related hazards have been identified, prioritized, and mitigated. The method for demonstrating this is human factors/usability engineering (HF/UE) validation testing. However, the way we conduct these studies is in many ways different from the way we conduct studies of non-medical products and systems.
This topic is relevant to the Boston UX community given the convergence of consumer and medical devices, as well as the rise of wearable technologies and the apps that interact with them. This presentation will cover the key aspects of HF/UE validation (a.k.a. ‘summative’) testing and what the FDA expects in the final HF/UE summary report.
Importantly, this session will consist of half presentation and half Q&A, with the audience driving the discussion toward current issues, questions, and challenges that are relevant to them.
mHealth Israel_Human Factors for MedTech Ergonomics and Usability_Rebecca MosesLevi Shapiro
Presentation by Rebecca Moses, Human Factors for MedTech Ergonomics and Usability, for the mHealth Israel community: Human Factors for MedTech Ergonomics and Usability
UX Antwerp Meetup, 27th of September 2016 - Carolien Creemers, Functional Analyst et Nobel Biocare
"UX design for better patient care"
When developing medical device software, UX design is more than facilitating a positive user experience. It is also about preventing your design decisions from leading to any patient harm. In this talk, Carolien will outline the challenges and risks that arise when designing software for daily clinical use.
She will give you some practical insights on how the team at Nobel Biocare developed a UX process in line with ISO and FDA regulations that delivers software which is not only easy to use but also safe to use.
Medical Device Development - Concept to Commercialization | Jahnavi Lokre | L...UCICove
About UCI Applied Innovation:
UCI Applied Innovation is a dynamic, innovative central platform for the UCI campus, entrepreneurs, inventors, the business community and investors to collaborate and move UCI research from lab to market.
About the Cove @ UCI:
To accelerate collaboration by better connecting innovation partners in Orange County, UCI Applied Innovation created the Cove, a physical, state-of-the-art hub for entrepreneurs to gather and navigate the resources available both on and off campus. The Cove is headquarters for UCI Applied Innovation, as well as houses several ecosystem partners including incubators, accelerators, angel investors, venture capitalists, mentors and legal experts.
Follow us on social media:
Facebook: @UCICove
Twitter: @UCICove
Instagram: @UCICove
LinkedIn: @UCIAppliedInnovation
For more information:
cove@uci.edu
http://innovation.uci.edu/
5 Key Considerations at the Start of SaMD DevelopmentICS
Changes introduced once the software development process has begun can have an adverse impact on budget, schedule and the product itself. Fortunately, meticulous planning can mitigate most last-minute changes and minimize the impact of those deemed absolutely necessary. This webinar will cover 5 key aspects you should address at the outset of the SaMD development process, from regulatory concerns to technology considerations, to keep your project running smoothly.
Investment in UCD Pays off
Bringing the users into every stage of the design process is an investment of effort and other resources of the design team, which makes understanding the benefits of a user-centered design approach relevant (IDF - www.interaction-design.org)
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...Greenlight Guru
The SARS-CoV-2 pandemic drastically changes the landscape of digital health innovation. The FDA authorized emergency use for a variety of SaMD products including but not limited to mental health, clinical decision support and remote monitoring software applications. In addition, FDA recently launched the Digital Health Center of Excellence, provided updates on the pre-certification program, and host a session to convey FDA’s current thinking on AI/ML SaMD validation.
SaMD manufacturers must keep up with the fast-evolving regulatory landscape and optimize their software development practices with a goal to demonstrate conformance to the QMS requirements effectively and efficiently.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
Quality Function Deployment (QFD) for Design ControlsEMMAIntl
The Food and Drug Administration (FDA) has requirements for medical device manufacturers to establish and maintain a quality system for their medical device(s). The requirement for a quality system does not necessarily introduce new concepts, but applies existing quality concepts to design, development, manufacturing, distribution and use of medical devices. Within the larger quality system requirement, a methodology to control device design and development of medical devices is required. This set of sub requirements is known as Design Controls. In this paper, the history and evolution of quality systems and their application to medical devices will be covered. A Quality tool that could be well applied to the specific area of design controls, Quality Function Deployment (QFD), is a focus of this paper.
Usability Challenges in Cutting-edge Medical Devices and Exoskeleton RoboticsICS
As medical device and robotics technology mature and grow more capable they also become more complex, requiring focus on usability aspects from both a user experience (UX) design and regulatory perspective. These new applications, such as exoskeletons, demand a seamless interaction between the device and the user. That means designers and developers must improve utility while mitigating inherent risks.
This online panel will explore how to approach UX design for medtech and how it should plug into a product development cycle leading to a 510(k) submission. We will share lessons learned from studying exoskeletons for military applications, and explain how they can be applied to medical/rehabilitative applications.
Similar to How User Experience Design and Human Factors Engineering can Accelerate Product Development (20)
The Compliance Concern: Challenges and Roadblocks for Ensuring Compliance in ...Greenlight Guru
The medical device industry is doubling down on compliance readiness. This is a significant shift from last year when we saw accelerating product development as the main goal. Ensuring compliance is a requirement for continued success, and most importantly, patient safety. The panelists will discuss the challenges device companies face as they manage compliance throughout the product lifecycle.
How Electronic Data Capture Is Transforming the MedTech IndustryGreenlight Guru
Clinical research is crucial to the life science industry. But did you know that medical device companies require a different approach? In this discussion, our panelists will talk about the challenges of clinical operations for MedTech, the benefits of leveraging MedTech-specific Electronic Data Capture (EDC) systems, the pitfalls of using outdated clinical data collection methods, such as paper, and much more!
The ROI of Shifting Mindset From Compliance to QualityGreenlight Guru
Many MedTech companies focus on compliance without considering the importance of quality. In this session, panelists will dive into the differences between compliance vs. quality, the benefits of shifting mindset towards quality, and tips on how to start embedding quality into your organization.
Leveraging Modern Software Technologies: MedTech’s Best Kept SecretGreenlight Guru
There are several moving pieces that influence a medical device company’s time-to-market and continued success. An often overlooked (yet critical) one is the tools used to manage the product lifecycle. Are your tools working for you or slowing down your success? In this session, panelists will discuss trends from the 2023 survey results, common challenges with disjointed software solutions, the impact of modernizing, and the power of a modern QMS.
Behind the Stats: Expectations vs. Reality of Bringing a Device to MarketGreenlight Guru
Learn about what’s currently impacting the broader medical device industry. Our panelists will kick off the week by going over all the trends, statistics, and themes uncovered from the 2023 MedTech Industry Benchmark Survey. The session will uncover major shifts in industry goals, the use of modern Medtech software tools, major gaps in product lifecycle processes, and more. Discover how you can apply these findings as you make decisions within your organization in 2023 and beyond.
Common Misconceptions on Medical Device Risk & Design ControlsGreenlight Guru
Learn about common misconceptions on medical device risk and design controls.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
QMSR Harmonization: The Future of FDA's Quality Management System RegulationGreenlight Guru
Learn about the future of FDA's Quality Management System regulation.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Today we will discuss why a QMS is the backbone of Regulatory through the lens of ISO 13845. The presentation will cover the importance of starting a QMS early and ahead of a regulatory strategy.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Modernizing your QMS to keep up with the Modern Age of RequirementsGreenlight Guru
Learn about the importance of a modern QMS to keep up with changing requirements in the MedTech industry.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
In this session we will learn about the Why, the What, the Who, and the How for Medical Device Reporting to FDA through eMDR Submissions.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Moving up to the State of the Art in Risk ManagementGreenlight Guru
During this presentation we will explore where Medical Device Risk Management Systems are today. We will look at the quickly upcoming deadlines for implementing the ISO 14971:2019 3rd Edition, and EN ISO 14971:2019/A11:2021 standards. We will also mention the potential next (4th) edition of ISO 14971, and how the industry may influence the next edition.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
While ISO 13485 is written in black and white, the alignment between the standard's requirements and expectations is not always clear - especially in regards to SaMD (software as a medical device). This session will discuss aligning ISO 13485 with best practices for SaMD, and how we can expect the shift of the industry to impact the anchor standard of the medical device industry.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceGreenlight Guru
Understand the FDA's new draft guidance on Computer Software Assurance (CSA).
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Making Headway Despite the Turbulence: Regulatory Requirements, Quality, and ...Greenlight Guru
The European Union’s In Vitro Diagnostic Medical Devices Regulation, or IVDR, became effective May 26, 2022. In this session, you’ll get a glimpse of what’s changed since implementation day, the latest guidance available, and ways to keep your IVDD to IVDR transition moving forward.
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Reducing Friction Between Companies and Regulatory BodiesGreenlight Guru
We are operating in a complex environment, which is still undergoing changes. A lack of regulatory/quality management resources can be seen on both notified bodies and the industry. To overcome these hurdles, close collaboration and communication between companies and the notified body is necessary.
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Latin American Regulations - What you Don't KnowGreenlight Guru
Central and South America are emerging as hot new Medical Device markets. These two subject matter experts in the area break down everything from regulatory advantages and ethical dilemmas.
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Insights on the MedTech Regulatory and Clinical Environment in IsraelGreenlight Guru
Facts about the high-tech industry of Israel
The new medical device law in Israel
The regulatory landscape - requirements and market access
Performing clinical trials in Israel
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
The Global Guide to Human Factors and Usability Engineering RegulationsGreenlight Guru
The regulatory landscape related to human factors and usability engineering has continued to evolve since FDA issued its draft guidance for human factors over ten years ago. In fact, the international standard for usability engineering, IEC 62366-1: 2015 was amended as recently as 2020. The good news is that the pathway to a successful regulatory strategy, in terms of human factors and usability engineering, has never been more clear. The regulators have spoken, by way of guidance and standards documents, all that is left to do is to make sense of it all as it relates to your specific device or product.
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Join industry expert, Danny Kroo, key takeaways from the session include: 1. What is MDSAP and when should you consider it? 2. How to prepare for an MDSAP certification audit 3. What are common nonconformities issued by auditing organizations
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
QMSR Harmonization - The Good the Bad and the UglyGreenlight Guru
Learn about the proposed QMSR rule, intended benefits of MDSAP for the regulatory authorities, benefits for the manufacturer, and similarities between ISO 13485 and FDA Regulations, and more!
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Attending a job Interview for B1 and B2 Englsih learnersErika906060
It is a sample of an interview for a business english class for pre-intermediate and intermediate english students with emphasis on the speking ability.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Improving profitability for small businessBen Wann
In this comprehensive presentation, we will explore strategies and practical tips for enhancing profitability in small businesses. Tailored to meet the unique challenges faced by small enterprises, this session covers various aspects that directly impact the bottom line. Attendees will learn how to optimize operational efficiency, manage expenses, and increase revenue through innovative marketing and customer engagement techniques.
As a business owner in Delaware, staying on top of your tax obligations is paramount, especially with the annual deadline for Delaware Franchise Tax looming on March 1. One such obligation is the annual Delaware Franchise Tax, which serves as a crucial requirement for maintaining your company’s legal standing within the state. While the prospect of handling tax matters may seem daunting, rest assured that the process can be straightforward with the right guidance. In this comprehensive guide, we’ll walk you through the steps of filing your Delaware Franchise Tax and provide insights to help you navigate the process effectively.
What are the main advantages of using HR recruiter services.pdfHumanResourceDimensi1
HR recruiter services offer top talents to companies according to their specific needs. They handle all recruitment tasks from job posting to onboarding and help companies concentrate on their business growth. With their expertise and years of experience, they streamline the hiring process and save time and resources for the company.
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...PaulBryant58
This article provides a comprehensive guide on how to
effectively manage the convert Accpac to QuickBooks , with a particular focus on utilizing online accounting services to streamline the process.
Unveiling the Secrets How Does Generative AI Work.pdfSam H
At its core, generative artificial intelligence relies on the concept of generative models, which serve as engines that churn out entirely new data resembling their training data. It is like a sculptor who has studied so many forms found in nature and then uses this knowledge to create sculptures from his imagination that have never been seen before anywhere else. If taken to cyberspace, gans work almost the same way.
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Skye Residences | Extended Stay Residences Near Toronto Airportmarketingjdass
Experience unparalleled EXTENDED STAY and comfort at Skye Residences located just minutes from Toronto Airport. Discover sophisticated accommodations tailored for discerning travelers.
Website Link :
https://skyeresidences.com/
https://skyeresidences.com/about-us/
https://skyeresidences.com/gallery/
https://skyeresidences.com/rooms/
https://skyeresidences.com/near-by-attractions/
https://skyeresidences.com/commute/
https://skyeresidences.com/contact/
https://skyeresidences.com/queen-suite-with-sofa-bed/
https://skyeresidences.com/queen-suite-with-sofa-bed-and-balcony/
https://skyeresidences.com/queen-suite-with-sofa-bed-accessible/
https://skyeresidences.com/2-bedroom-deluxe-queen-suite-with-sofa-bed/
https://skyeresidences.com/2-bedroom-deluxe-king-queen-suite-with-sofa-bed/
https://skyeresidences.com/2-bedroom-deluxe-queen-suite-with-sofa-bed-accessible/
#Skye Residences Etobicoke, #Skye Residences Near Toronto Airport, #Skye Residences Toronto, #Skye Hotel Toronto, #Skye Hotel Near Toronto Airport, #Hotel Near Toronto Airport, #Near Toronto Airport Accommodation, #Suites Near Toronto Airport, #Etobicoke Suites Near Airport, #Hotel Near Toronto Pearson International Airport, #Toronto Airport Suite Rentals, #Pearson Airport Hotel Suites
Remote sensing and monitoring are changing the mining industry for the better. These are providing innovative solutions to long-standing challenges. Those related to exploration, extraction, and overall environmental management by mining technology companies Odisha. These technologies make use of satellite imaging, aerial photography and sensors to collect data that might be inaccessible or from hazardous locations. With the use of this technology, mining operations are becoming increasingly efficient. Let us gain more insight into the key aspects associated with remote sensing and monitoring when it comes to mining.
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
Pitch Deck Teardown: RAW Dating App's $3M Angel deck
How User Experience Design and Human Factors Engineering can Accelerate Product Development
1. How User Experience Design and
Human Factors Engineering can
Accelerate Product Development
1
2.
3. Who is UserWise?
3
UserWise works with medical product
companies to:
• Fulfill all steps of the Usability
Engineering Process
• Maintain compliance to applicable
standards and regulations:
• 2016 FDA/CDRH Human Factors
Guidance for Medical Devices
• IEC 62366:2007 and/or IEC
62366-1:2015
• IEC 60601-1-6
• ISO 14971.
4. To inspire usability engineering best practices within medical product companies
and to facilitate the development of usable medical products.
Company Mission
4
5. About ICS
5
● Founded in 1987, 120 employees
● HQ in Boston, offices in the Bay Area and Ottawa
● We provide:
○ UX design
○ Full-stack custom software development services
○ IS0 13485-compliant development process
○ Linux and QNX platform and board support
○ Full end-to-end product realization
○ Qt training
● Our UX First approach means products we design are
developed on time and on budget
● We deliver 70+ projects annually for global brands
6. Boston UX
● Offer a full suite of user experience services:
○ Product vision and direction
○ UX design
○ Visual & motion design
○ Voice integration design
○ Usability research and testing
● IEC 62366 compliant process
www.bostonux.com
7. What is Human Factors Engineering,
and why is it important?
7
8. Human Factors Engineering
8
The FDA defines Human Factors as “the application of knowledge about human
behavior, abilities, limitations…to the design of medical devices including…
• mechanical and software
driven interfaces,
• user documentation, and
• user training
…to enhance and demonstrate safe
and effective use.”
9. Why is Human Factors Engineering Important?
9
Conservatively estimated, there are 210,000 preventable hospital
deaths annually in the United States.
J Patient Saf & Volume 9, Number 3, September 2013
11. Implement Human Factors Early in the Development Process
11
Cost WITH
Human Factors
Development phase (Time)
Investment Cost WITHOUT
Human Factors
12. Implement Human Factors Early in the Development Process
12
Cost WITH
Human Factors
Pass validation testing at first
attempt
Iterative design - make
mistakes early and
often
Apply correct user
requirements, design
standards and
assumptions
Development phase (Time)
Investment Cost WITHOUT
Human Factors
13. Implement Human Factors Early in the Development Process
13
Late realization
of mismatch
between user
expectations
and product
design
Applying last-minute
design changes
Expensive training and
support due to
ease-of-use issues
Apply long-term
support costs
Development phase (Time)
Investment
Unexpected validation
results – features need to
be modified & re-validated
Cost WITHOUT
Human Factors
Cost WITH
Human Factors
15. NicoletOne vEEG System (Software) by CareFusion - 2010 Recall
15
● Software led users to confuse the left and right sides of patient’s brain
● This depiction of brain hemispheres is inherently confusing. The person’s right
side is labelled ‘left’ and vice-versa
16. What are the Human Factors Guidance
and Regulations?
16
17. Code of Federal Regulations (CFR) – Quality System Regulation
17
18. FDA Focus on Human Factors and Industry Response
18
Quality System
Regulations (1996)
1st
FDA Guidance,
Human Factors (2000)
Human Factors Team
formed at FDA’s Office
of Device Evaluation
(2007)
FDA boosts
organization’s Human
Factors Staff (2015)
ImprovedapplicationofHF
Time and Events
Human Factors/Usability for Medical Devices: An Historical Perspective, Ron Kaye Office of Device Evaluation, CDRH,
Food and Drug Administration, NIST Workshop on Usability and EHR Technology, June 7, 2011.
23. The Human Factors Process
23
User Research Risk Analysis Iterative Prototyping &
Usability Testing
Usability Validation Human Factors
Submission
24. User Research
24
• Who will be the device Users?
• What are their characteristics, capabilities, training and background?
• How does the user profile impact the potential design?
• What environmental conditions will the device be used in?
Physicians EMTsSurgeons General Population Elderly Patients
25. Known Use Problem Summary
25
Identifying Known Use Problems:
Use Problems
• 1st
Generation
Products
• Competitive
Products
• Similar Products
Complaints
MDRs
Literature
Internet Data
Use-Related
Risk
Analysis
User Interviews
Customer Service
RecallsSales
Representatives
For FDA and CE Submissions
26. Use-Related Risk Analysis (Use FMEA)
26
Use-Related
Risk Analysis
Analytical &
Empirical Methods
to Identify Use
Errors
User Profiles
Use Environment
27. Use Error Definitions
27
Use Error (IEC 62366-1): User action or lack of USER action while using the
MEDICAL DEVICE that leads to a different result than that intended by the
MANUFACTURER or expected by the USER.
Use Error (FDA): User action or lack of action that was different from that
expected by the manufacturer and caused a result that
(1) was different from the result expected by the user and
(2) was not caused solely by device failure and
(3) did or could result in harm
28. Usability Testing
28
• Early-Stage Formative Studies on
mock-ups and prototypes
• Later-Stage End-to-End Formative
Studies to confirm readiness for
Validation
• Final Summative Usability/Human
Factors Validation Testing for
regulatory submissions
29. FDA Guidelines for Design of a Human Factors Validation Study
29
The human factors validation testing should be designed as
follows:
• Sample size of at least n=15 per user profile.
• Participants must be US Residents
• Participants must have representative training (or lack of
training), and appropriate training decay
• Participants must have no prior exposure to the product
• Participants must use the device independently and
naturally, without interference or influence from the facilitator
or moderator.
We typically recruit 18 participants per user profile to account for no
shows/disqualified participants
30. Usability Testing Considerations During the COVID-19 Pandemic
30
Special modifications should be made to usability tests to
minimize the risk of transmission of the novel coronavirus:
● All participants and the study team should be equipped
with necessary PPE, including gloves and face masks
● The study articles, equipment, and surfaces in the study
room should be wiped down with disinfectant between
study sessions
● The study team should require participants to inform the
study team if they show symptoms prior to or within 2
weeks after the study session
● Remote moderation and observation is encouraged
● Government rules and regulations supersede the study
protocol
32. Vignette – Safe vs. Easy (per FDA)
Human Factors
Applying knowledge of human abilities/limitations to device design
Usability User Experience
- Risk Mitigation
- Safe & effective use
- Learnable
- Efficient
- Delightful
33. ● USERS AND ENVIRONMENTS Identify and
analyze intended users and expected use scenarios
and use environments
● HAZARDS AND CONSEQUENCES Identify
and explore potential device use‐related hazards and
risks, and their potential clinical consequences
● IMPLEMENT CONTROLS Explore different
design alternatives, and test that they’re effective
Reasonableness of the HF/UX Rationale
(IEC 62366)
Define intended use,
users, environment
Identify use related
hazards
Estimate & prioritize use
error risk
Implement risk controls
Validate safety of use
Risk Acceptable?
New risks
Introduced?
Document Process
Monitor unanticipated
risks in post market
Yes
YesNo
No
34. Using UX to Feed Regulatory Development
DEFINE & ANALYZE
RAPID SOFTWARE
PROTOTYPING
FORMATIVE STUDIES CONVERT PROTOTYPES
TO APPLICATION
DEVELOP BACK END
SOFTWARE
Begin Design Controls
21 CFR 820, ISO 13485 - Design Control and QMSIEC 62366 - Human Factors and Usability Standard
35. Using UX to Feed Development
21 CFR 820, ISO 13485 - Design Control and QMS
DEFINE & ANALYZE
RAPID SOFTWARE
PROTOTYPING
IEC 62366 - Human Factors and Usability Standard
FORMATIVE STUDIES
CONVERT TO FRONT END
APPLICATION
FRAMEWORK
DEVELOP BACK END
SOFTWARE
● User research
● Functional analysis
● Task analysis
● Hazard analysis
● Design specifications
● User interface design with
Industry leading tools
● Quick, efficient product
realization
● UX Specifications
● High Fidelity Prototyping
● Early, inexpensive, design
modification
● GUI Navigation, GUI
Definition, Summative
Criteria
● Documented support for
FDA’s HFE/UE report
● Application Framework
● Built in software
architecture
● Framework Unit Tests
Product Requirements
Software and System
Specifications
Verification and
Validation
FDA Submission
36. Vignette: UOUP for Legacy UI
SOUP = Software Of Unknown Provenance
UOUP = SOUP on a UI = UI without IEC 62366
1) Perform full usability processes on all parts of the UI (5.1-5.9), or
2) Post-market analysis and report , or
3) Rationale to not apply usability procedures to legacy UI
37. Key Takeaways - How UX Design Streamlines Development
High Fidelity Prototypes
(pre-engineering)
Fewer late stage changes
UX Specifications
(Conditional UI behaviors “shall alert until
message acknowledged”)
Software Engineers
UI Definition
(Every UI, All Navigation)
Test Engineers
Define and Prototype
(IEC 62366 documentation)
HFE/UE Report for 510K